JP2015502368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502368A5 JP2015502368A5 JP2014547553A JP2014547553A JP2015502368A5 JP 2015502368 A5 JP2015502368 A5 JP 2015502368A5 JP 2014547553 A JP2014547553 A JP 2014547553A JP 2014547553 A JP2014547553 A JP 2014547553A JP 2015502368 A5 JP2015502368 A5 JP 2015502368A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- compound
- composition according
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576720P | 2011-12-16 | 2011-12-16 | |
| US61/576,720 | 2011-12-16 | ||
| PCT/US2012/070190 WO2013090931A2 (en) | 2011-12-16 | 2012-12-17 | Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156321A Division JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502368A JP2015502368A (ja) | 2015-01-22 |
| JP2015502368A5 true JP2015502368A5 (enExample) | 2015-11-05 |
Family
ID=48613379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547553A Withdrawn JP2015502368A (ja) | 2011-12-16 | 2012-12-17 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
| JP2017156321A Pending JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156321A Pending JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150045301A1 (enExample) |
| EP (1) | EP2790714A4 (enExample) |
| JP (2) | JP2015502368A (enExample) |
| CN (2) | CN104039341A (enExample) |
| CA (1) | CA2853204A1 (enExample) |
| HK (1) | HK1202433A1 (enExample) |
| WO (1) | WO2013090931A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106822182A (zh) * | 2016-12-27 | 2017-06-13 | 广州姿生生物科技有限公司 | 一种细胞提取物及其用途 |
| US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5962406A (en) | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
| JPH10273450A (ja) * | 1997-03-27 | 1998-10-13 | Toagosei Co Ltd | 眼内血管新生性疾患治療薬 |
| KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
| EP1727556A2 (en) * | 2004-02-17 | 2006-12-06 | University Of South Florida | Materials and methods for treatment of inflammatory and cell proliferation disorders |
| US20070049251A1 (en) | 2005-08-31 | 2007-03-01 | Mock Von A | Method and system for wireless communication in emergency situations |
| US20100204107A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of urodilatin as a therapeutic agent |
| WO2009043468A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of corticotropin-releasing factor as a therapeutic agent |
| AU2008303928A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection |
| KR20100059863A (ko) * | 2007-09-11 | 2010-06-04 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 티모신 베타 ４ 단독 또는 세크로핀 ａ와의 배합물의 용도 |
| JP2011509248A (ja) * | 2007-12-28 | 2011-03-24 | カルロス・セラピューティクス、インク | 抗細胞増殖化合物およびその使用方法 |
| US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| PH12012500562A1 (en) * | 2009-09-25 | 2012-10-22 | Takeda Pharmaceuticals Co | Novel npr-b antagonists |
| WO2011075471A2 (en) * | 2009-12-18 | 2011-06-23 | Alcon Research, Ltd. | Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
-
2012
- 2012-12-17 CA CA2853204A patent/CA2853204A1/en not_active Abandoned
- 2012-12-17 US US14/365,517 patent/US20150045301A1/en not_active Abandoned
- 2012-12-17 HK HK15103021.0A patent/HK1202433A1/xx unknown
- 2012-12-17 JP JP2014547553A patent/JP2015502368A/ja not_active Withdrawn
- 2012-12-17 CN CN201280062142.XA patent/CN104039341A/zh active Pending
- 2012-12-17 EP EP12858180.8A patent/EP2790714A4/en not_active Withdrawn
- 2012-12-17 CN CN201810139954.9A patent/CN108653715A/zh active Pending
- 2012-12-17 WO PCT/US2012/070190 patent/WO2013090931A2/en not_active Ceased
-
2017
- 2017-08-14 JP JP2017156321A patent/JP2018024674A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210283108A1 (en) | Method for treating neurodegenerative diseases | |
| Sheibani et al. | Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization | |
| JP6666899B2 (ja) | Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法 | |
| JP7726791B2 (ja) | 補体活性を調節するための組成物及び方法 | |
| JP7280619B2 (ja) | ペプチド組成物 | |
| JP2014511858A5 (enExample) | ||
| US20240218018A1 (en) | Compstatin Analogs with Increased Solubility and Improved Pharmacokinetic Properties | |
| ES2755053T3 (es) | Composición para el tratamiento de lesiones cerebrales | |
| JP2016523274A (ja) | 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用 | |
| US20200222548A1 (en) | Synthetic bioconjugates | |
| CN116917482A (zh) | 嵌合蛋白和治疗中枢神经系统疾病的方法 | |
| Jiang et al. | Eyedrop delivery of therapeutic proteins with zwitterionic polymers to treat dry age-related macular degeneration | |
| KR20200026918A (ko) | 화학적으로 변형된 백본을 갖는 생체접합체 | |
| AR079683A1 (es) | Formulacion topica oftalmica de peptidos | |
| WO2025022842A1 (ja) | ドライアイの治療剤又は予防剤 | |
| JP2018536650A5 (enExample) | ||
| CA3022152A1 (en) | Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseases | |
| WO2008075365A1 (en) | Compositions and methods for treatment of age related degeneration of the retina | |
| WO2011097577A2 (en) | Compositions and methods for treating or preventing retinal degeneration | |
| US9913877B2 (en) | Methods and compositions for the treatment of axonal and neuronal degeneration | |
| JP2024540178A (ja) | 修飾アルギン酸塩、ならびにその製造方法および使用方法 | |
| JP6046060B2 (ja) | エイズの治療のための、ポリアニオン性ポリペプチドと結合しているｃｄ４受容体由来ペプチドを含んでなる新規コンジュゲート分子 | |
| WO2019048851A1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| KR102023827B1 (ko) | 안구 건조증 질환의 치료 및/또는 예방을 위한 짧은 합성 펩티드의 용도 | |
| WO2019048854A1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES |